IRIS
SIRACUSA, Rosalba
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.970
EU - Europa 2.940
AS - Asia 615
SA - Sud America 6
OC - Oceania 5
AF - Africa 1
Totale 6.537
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.967
IE - Irlanda 1.091
SE - Svezia 739
IT - Italia 623
CN - Cina 475
PL - Polonia 234
IN - India 75
DE - Germania 73
VN - Vietnam 48
AT - Austria 33
BE - Belgio 33
FI - Finlandia 32
GB - Regno Unito 26
UA - Ucraina 21
FR - Francia 12
RU - Federazione Russa 7
HK - Hong Kong 6
NL - Olanda 6
BR - Brasile 5
MY - Malesia 5
AU - Australia 4
CA - Canada 3
PT - Portogallo 3
BA - Bosnia-Erzegovina 2
AR - Argentina 1
BD - Bangladesh 1
BG - Bulgaria 1
EE - Estonia 1
EG - Egitto 1
ES - Italia 1
ID - Indonesia 1
IL - Israele 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PH - Filippine 1
RS - Serbia 1
SG - Singapore 1
TW - Taiwan 1
Totale 6.537
Salva come PNG Salva come JPEG
Città #
Dublin 1.091
Chandler 707
Nyköping 606
Warsaw 232
Princeton 206
Messina 204
Beijing 171
Ashburn 155
Medford 155
Ann Arbor 132
Des Moines 114
Jacksonville 100
Dearborn 92
New York 69
Cologne 52
Dong Ket 47
Houston 45
Wilmington 43
Jinan 42
Pune 37
Shenyang 35
Cambridge 34
San Mateo 34
Brussels 33
Vienna 33
Boardman 31
Hyderabad 27
Falls Church 23
Milan 23
Nanjing 23
Catania 21
Ningbo 21
Zhengzhou 20
Rome 19
Tianjin 18
Hangzhou 17
Lancaster 15
Francofonte 14
Guangzhou 14
Hebei 13
Taizhou 13
Fuzhou 12
Haikou 12
Nanchang 12
Seattle 12
Pace 11
Lanzhou 10
Misterbianco 10
Acireale 9
Fairfield 9
Helsinki 9
Naples 9
Bremen 7
Florence 7
Jiaxing 7
Palermo 7
Borghetto Santo Spirito 6
Kyiv 6
Norwalk 6
Brescia 5
Carini 5
Floridia 5
Lago 5
Los Angeles 5
Napoli 5
Alessandria 4
Cagliari 4
Changsha 4
Chortkiv 4
Foggia 4
Hong Kong 4
Noto 4
Reggio Calabria 4
Shah Alam 4
Washington 4
Acate 3
Bari 3
Berlin 3
Bologna 3
Bronte 3
Brooklyn 3
Caserta 3
Corigliano Calabro 3
Council Bluffs 3
Ferrara di Monte Baldo 3
Genoa 3
Hefei 3
Mumbai 3
Paris 3
Tappahannock 3
Troina 3
Udine 3
Aci Sant'antonio 2
Benevento 2
Brisbane 2
Caprino Veronese 2
Cardiff 2
Centro 2
Cesano Maderno 2
Chaves 2
Totale 5.079
Salva come PNG Salva come JPEG
Nome #
The association of adelmidrol with sodium hyaluronate displays beneficial properties against bladder changes following spinal cord injury in mice 115
N-Palmitoylethanolamine-oxazoline (PEA-OXA): A new therapeutic strategy to reduce neuroinflammation, oxidative stress associated to vascular dementia in an experimental model of repeated bilateral common carotid arteries occlusion 111
Neuroinflammation and Oxidative Stress in the Traumatic Brain Injury and in the Pathogenesis of Neurodegenerative Diseases: Modulation by Nutritional Supplementation 99
Adelmidrol, a palmitoylethanolamide analogue, as a new pharmacological treatment for the management of inflammatory bowel disease 93
The neuroprotective effects of co-ultraPEALut in a mouse model of spinal cord injury 89
Adaptation to oxidative stress at cellular and tissue level 85
Erratum to: Micronized/ultramicronized palmitoylethanolamide displays superior oral efficacy compared to nonmicronized palmitoylethanolamide in a rat model of inflammatory pain 84
Beneficial Effects of Co-Ultramicronized Palmitoylethanolamide/Luteolin in a Mouse Model of Autism and in a Case Report of Autism 78
The anti-inflammatory and antioxidant potential of pistachios (Pistacia vera L.) in vitro and in vivo 76
Fumaric Acid Esters Attenuate Secondary Degeneration and Promote Functional Recovery Following Experimental Spinal Cord Injury 74
The Neuroprotective Effects of Micronized PEA (PEA-m) Formulation on Diabetic Neuropathy in Mice 73
Liver X receptors activation, through TO901317 binding, reduces neuroinflammation in Parkinson's disease 71
2-Pentadecyl-2-Oxazoline reduces neuroinflammatory environment in the MPTP model of Parkinson Disease 71
Adelmidrol + sodium hyaluronate in IC/BPS or conditions associated to chronic urothelial inflammation. A translational study 69
Astrocytes: Role and Functions in Brain Pathologies 69
The Association of Palmitoylethanolamide with Luteolin Decreases Autophagy in Spinal Cord Injury 69
KU0063794, a Dual mTORC1 and mTORC2 Inhibitor, Reduces Neural Tissue Damage and Locomotor Impairment After Spinal Cord Injury in Mice 68
2-Pentadecyl-2-oxazoline, the oxazoline of PEA, modulates carrageenan-induced acute inflammation 66
Co-ultramicronized palmitoylethanolamide/luteolin promotes neuronal regeneration after spinal cord injury 65
N-palmitoylethanolamide Prevents Parkinsonian Phenotypes in Aged Mice 65
Adelmidrol: A New Promising Antioxidant and Anti-Inflammatory Therapeutic Tool in Pulmonary Fibrosis 64
Anti-inflammatory and neuroprotective effects of co-ultraPEALut in a mouse model of vascular dementia 62
Effects of palmitoylethanolamide and silymarin combination treatment in an animal model of kidney ischemia and reperfusion 61
Gut-Brain Actions Underlying Comorbid  Neuropsychiatric Disturb Associated with Inflammatory Bowel Disease 61
The Association of Palmitoylethanolamide with Luteolin Decreases Neuroinflammation and Stimulates Autophagy in Parkinson's Disease Model 59
Neuroprotective effects of oxidative preconditioning against apoptosis induced by H2O2 in differentiated neuroblastoma SH-SY5Y cells 59
Gut–Brain Actions Underlying Comorbid Neuropsychiatric Disturb Associated With Inflammatory Bowel Disease 59
A new co-micronized composite containing palmitoylethanolamide and polydatin shows superior oral efficacy compared to their association in a rat paw model of carrageenan-induced inflammation 58
Therapeutic efficacy of palmitoylethanolamide and its new formulations in synergy with different antioxidant molecules present in diets 58
N-Palmitoylethanolamide-oxazoline Treatments Protects Against Neuroinflammatory Injury Induced by Transient Middle Cerebral Artery Occlusion in Diabetic Rats 57
Absence of formyl peptide receptor 1 causes endometriotic lesion regression in a mouse model of surgically-induced endometriosis 56
2-Pentadecyl-2-Oxazoline reduces neuroinflammatory environment in the MPTP model of Parkinson Disease 55
2-Pentadecyl-2-Oxazoline Reduces Neuroinflammatory Environment in the MPTP Model of Parkinson Disease 54
Effects of a co-micronized composite containing palmitoylethanolamide and polydatin in an experimental model of benign prostatic hyperplasia 53
Formyl Peptide Receptor 1 Signaling in Acute Inflammation and Neural Differentiation Induced by Traumatic Brain Injury 52
Protective Effects of Ultramicronized Palmitoylethanolamide (PEA-UM®) in Myocardial Ischaemia and Reperfusion Injury in Vivo 51
Micronized/ultramicronized palmitoylethanolamide displays superior oral efficacy compared to nonmicronized palmitoylethanolamide in a rat model of inflammatory pain 51
Protective effect of polyphenols in an inflammatory process associated with experimental pulmonary fibrosis in mice 51
Neuroprotective Effects of Temsirolimus in Animal Models of Parkinson's Disease 51
Neuronal‐like differentiated SH‐SY5Y cells adaptation to a mildand transient H2O2‐induced oxidative stress 50
KU0063794, a dual mTORC1 and mTORC2 inhibitor, reduces neural tissue damage and locomotor impairment after spinal cord injury in mice 50
Ultramicronized palmitoylethanolamide (PEA-um(®)) in the treatment of idiopathic pulmonary fibrosis 49
Redox modulation of cellular stress response and lipoxin A4 expression by Coriolus versicolor in rat brain: Relevance to Alzheimer's disease pathogenesis 49
Co-ultraPEALut: Role in Preclinical and Clinical Delirium Manifestations 48
N-acetyl-L-cysteine reduces Leishmania amazonensis-induced inflammation in BALB/c mice 48
Co-ultra PEALut enhances endogenous repair response following moderate traumatic brain injury 48
Inhibition of Poly(ADP-Ribose) Polymerase Activity Modulates Autophagy Induced by Experimental Spinal Cord Trauma 47
The antioxidant and anti-inflammatory properties of Anacardium occidentale l. Cashew nuts in a mouse model of colitis 46
N-Palmitoylethanolamide-Oxazoline Protects against Middle Cerebral Artery Occlusion Injury in Diabetic Rats by Regulating the SIRT1 Pathway 45
Assessment of 2-Pentadecyl-2-oxazoline Role on Lipopolysaccharide-Induced Inflammation on Early Stage Development of Zebrafish (Danio rerio) 45
Effect of PEA-OXA on neuropathic pain and functional recovery after sciatic nerve crush 44
Safety and efficacy of a new micronized formulation of the ALIAmide palmitoylglucosamine in preclinical models of inflammation and osteoarthritis pain 44
Protective effects of Colomast®, A New Formulation of Adelmidrol and Sodium Hyaluronate, in A Mouse Model of Acute Restraint Stress 44
Micronized palmitoylethanolamide (PEA-m): a new pharmacological strategy to prevent neurodegenerative disease associated to the old age 43
Neuroprotection by association of palmitoylethanolamide with luteolin in experimental alzheimer’s disease models: the control of neuroinflammation 43
Effects of Hydroxytyrosol against Lipopolysaccharide-Induced Inflammation and Oxidative Stress in Bovine Mammary Epithelial Cells: A Natural Therapeutic Tool for Bovine Mastitis 43
Effects of a new compound containing Palmitoylethanolamide and Baicalein in myocardial ischaemia/reperfusion injury in vivo 42
Biochemical Evaluation of the Antioxidant Effects of Hydroxytyrosol on Pancreatitis-Associated Gut Injury 42
Aflatoxin b1 toxicity in zebrafish larva (Danio rerio): Protective role of hericium erinaceus 42
RUOLO DELL’AUTOFAGIA NELLA NEUROINFIAMMAZIONE ASSOCIATA A LESIONI SPINALI 41
FeTTPs treatment reduces secondary injury associated in a mouse model of traumatic brain injury 41
Anti-inflammatory and Anti-oxidant Activity of Hidrox® in Rotenone-Induced Parkinson’s Disease in Mice 41
Autophagy and mitophagy promotion in a rat model of endometriosis 41
Anti-inflammatory and neuroprotective effects of co-ultraPEALut in a mouse model of vascular dementia 41
PPAR-α Modulates the Anti-Inflammatory Effect of Melatonin in the Secondary Events of Spinal Cord Injury 40
N-Palmitoylethanolamine-Oxazoline as a New Therapeutic Strategy to Control Neuroinflammation: Neuroprotective Effects in Experimental Models of Spinal Cord and Brain Injury 40
Therapeutic potential of dinitrobenzene sulfonic acid (DNBS)-induced colitis in mice by targeting IL-1beta and IL-18 40
Oral ultramicronized palmitoylethanolamide: Plasma and tissue levels and spinal anti-hyperalgesic effect 40
Topical application of adelmidrol + trans-traumatic acid enhances skin wound healing in a streptozotocin-induced diabetic mouse model 40
The neuroprotective effects of micronized PEA (PEA-m) formulation on diabetic peripheral neuropathy in mice 40
Adelmidrol, a palmitoylethanolamide analogue, as a new pharmacological treatment for the management of inflammatory bowel disease 40
Melatonin plus folic acid treatment ameliorates reserpine-induced fibromyalgia: An evaluation of pain, oxidative stress, and inflammation 40
Protective effect of a new hyaluronic acid -carnosine conjugate on the modulation of the inflammatory response in mice subjected to collagen-induced arthritis 40
The protective effects of pre-and post-administration of micronized palmitoylethanolamide formulation on postoperative pain in rats 40
Effects of different natural extracts in an experimental model of benign prostatic hyperplasia (BPH) 39
Protective Effect of Hydroxytyrosol on LPS-Induced Inflammation and Oxidative Stress in Bovine Endometrial Epithelial Cell Line 39
Environmental Risk Assessment of Oxaliplatin Exposure on Early Life Stages of Zebrafish (Danio rerio) 38
Redox modulation of cellular stress response and lipoxin A4 expression by Hericium Erinaceus in rat brain: relevance to Alzheimer's disease pathogenesis 38
Effect of Cannabidiol (CBD) on Canine Inflammatory Response: An Ex Vivo Study on LPS Stimulated Whole Blood 38
TLR4 absence reduces neuroinflammation and inflammasome activation in Parkinson's diseases in vivo model 37
Effect of co-ultramicronized palmitoylethanolamide and luteolin association on neurogenesis in a mouse model of spinal cord injury 37
The protective effect of new carnosine-hyaluronic acid conjugate on the inflammation and cartilage degradation in the experimental model of osteoarthritis 37
Effect of artesunate on leishmania amazonesis induced neuroinflammation and nociceptive behavior in male BALB/C mice 37
Cashew (Anacardium occidentale L.) Nuts Counteract Oxidative Stress and Inflammation in an Acute Experimental Model of Carrageenan-Induced Paw Edema 37
Atrazine Inhalation Worsen Pulmonary Fibrosis Regulating the Nuclear Factor-Erythroid 2-Related Factor (Nrf2) Pathways Inducing Brain Comorbidities 37
null 36
Ultramicronized palmitoylethanolamide and paracetamol, a new association to relieve hyperalgesia and pain in a sciatic nerve injury model in rat 36
Synergic therapeutic potential of PEA-Um treatment and NAAA enzyme silencing in the management of neuroinflammation 36
Role of Etanercept and Infliximab on Nociceptive Changes Induced by the Experimental Model of Fibromyalgia 35
Palmitoylethanolamide treatment reduces retinal inflammation in streptozotocin-induced diabetic rats 35
Gut-Brain Actions Underlying Comorbid Neuropsychiatric Disturb Associated with Inflammatory Bowel Disease. 35
Novel combination of cox-2 inhibitor and antioxidant therapy for modulating oxidative stress associated with intestinal ischemic reperfusion injury and endotoxemia 35
Mucosa-associated lymphoid tissue lymphoma translocation 1 inhibitor as a novel therapeutic tool for lung injury 35
Açaí (Euterpe Oleraceae Mart.) Seeds Regulate NF-κB and Nrf2/ARE Pathways Protecting Lung against Acute and Chronic Inflammation 34
Neuroprotection by association of palmitoylethanolamide with luteolin in experimental Alzheimer’s disease models: the control of neuroinflammation. 34
A novel protective formulation of Palmitoylethanolamide in experimental model of contrast agent induced nephropathy 34
mTOR Pathway Inhibition Prevents Neuroinflammation and Neuronal Death in a Mouse Model of Spinal Cord Injury 34
PEA-OXA as new therapeutic strategy to control neuroinflammation in experimental model of spinal cord and brain injury 34
Antiinflammatory and neuroprotective effects of co-ultraPEALut in a mouse model of vascular dementia 34
N-Palmitoylethanolamine-oxazoline (PEA-OXA): a new therapeutic strategy to reduce neuroinflammation and oxidative stress associated to vascular dementia 34
Totale 5.114
Salva come PNG Salva come JPEG
Categoria #
all - tutte 29.478
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 29.478
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20198 0 0 0 0 0 0 0 0 0 0 5 3
2019/2020617 3 4 1 95 7 97 55 40 35 172 71 37
2020/20211.029 35 29 222 67 136 28 55 117 174 97 12 57
2021/20221.137 20 79 43 43 81 31 106 41 25 59 119 490
2022/20233.150 265 277 146 204 223 275 50 178 1.350 41 103 38
2023/2024821 83 133 60 75 82 178 81 73 10 40 6 0
Totale 6.978